Kolexia
Durigova Anna Oncologie médicale
Durigova Anna
Oncologie médicale
Centre Hospitalier de Compiègne
Compiègne, France
36 Activités
323 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Anémie Anémie par carence en fer Effets secondaires indésirables des médicaments Carence en vitamine D Inflammation Léiomyosarcome Hypertriglycéridémie

Collaborateurs

Voir plus
Aldabbagh Kais
Aldabbagh Kais
Cabinet libéral, Compiègne, France
Jacot William
Jacot William
Icm Montpellier, Montpellier, France
Pouderoux Stephane
Pouderoux Stephane
Icm Montpellier, Montpellier, France
Lamy Pierre-Jean
Lamy Pierre-Jean
Inovie Labosud Montpellier Chedeville, Montpellier, France

Industries

Voir plus
Lilly
1 collaboration(s)
Dernière en 2020
Novartis
1 collaboration(s)
Dernière en 2020
AstraZeneca
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
5-Fluorouracil-associated severe hypertriglyceridaemia with positive rechallenge.
BMJ case reports   19 décembre 2023
Leiomyosarcoma of the lower rectum managed by radiotherapy and surgery: A case report and review of literature.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   22 avril 2023
Precision medicine in early breast cancer-beginning of a successful story?
ESMO open   27 janvier 2023
VITACAL: Randomized Phase III Trial Comparing Conventional Vitamin D Supplementation vs. Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients Treated by Neoadjuvant or Adjuvant Chemotherapy.
Essai Clinique (Institut du Cancer de Montpellier)   06 septembre 2019
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Breast cancer research and treatment   11 juillet 2019
MIRHO: Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer? Pilot Study.
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   02 mars 2018
Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.
British journal of cancer   13 février 2018
Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology   30 mars 2016
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
BMC cancer   08 octobre 2015
Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   26 mai 2015